Massachusetts · Bill 1074 · 193rd General Court

An Act relative to cancer patient access to biomarker testing to provide appropriate therapy

  1. Introduced Feb 16, 2023
  2. In committee Feb 16, 2023
  3. Died  
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

By Representative Kilcoyne of Clinton, a petition (accompanied by bill, House, No. 1074) of Meghan Kilcoyne and others relative to cancer patient access to biomarker testing to provide appropriate therapy. Financial Services.

Every action

9 steps, oldest first, as the legislature records them.

  1. CommitteeReferred to the committee on Financial Services · Joint Committee on Financial Services
  2. SenateSenate concurred
  3. CommitteeHearing rescheduled to 05/02/2023 from 10:00 AM-01:00 PM in Gardner Auditorium · Joint Committee on Financial Services
  4. HouseReporting date extended to Friday May 17, 2024, pending concurrence
  5. SenateSenate concurred
  6. CommitteeReported favorably by committee and referred to the committee on Health Care Financing · Joint Committee on Health Care Financing
  7. HouseAccompanied by S689
  8. CommitteeCommittee recommended bill ought to pass and referred to the committee on House Ways and Means · House Committee on Ways and Means
  9. HouseNo further action taken

Roll calls

No recorded votes on this bill yet.

Sponsors

The member who introduced it, joined by 77 cosponsors: 65 Democrats, 12 Republicans.

All 77 cosponsors

From Massachusetts's official records (malegislature.gov/api), checked Nov 14, 2026. Text links go to the official versions; LegiList does not copy bill text.